Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peritoneal clearance of amphotericin B and 5-fluorocytosine.

Literature DB >> 7015695

Peritoneal clearance of amphotericin B and 5-fluorocytosine.

R S Muther, W M Bennett.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1980 PMID： 7015695 PMCID： PMC1272234

Source DB: PubMed Journal: West J Med ISSN： 0093-0415

× No keyword cloud information.

12 in total

1. Treatment of Candida peritonitis by peritoneal lavage with amphotericin B.

Authors: R A Bortolussi; M R MacDonald; R M Bannatyne; G S Arbus
Journal: J Pediatr Date: 1975-12 Impact factor: 4.406

2. Candida peritonitis treated with 5-fluorocytosine in a patient receiving hemodialysis.

Authors: I Phillips; S Eykyn; G A MacGregor; N F Jones
Journal: Clin Nephrol Date: 1973 Jul-Aug Impact factor: 0.975

3. Candida peritonitis in a quadriplegic: treatment with amphotericin B.

Authors: K O Reeves; A C Ripepi; R E Carter; T W Williams
Journal: South Med J Date: 1972-03 Impact factor: 0.954

4. The kinetics of 5-fluorocytosine elimination in man.

Authors: D N Wade; G Sudlow
Journal: Aust N Z J Med Date: 1972-05

5. Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man.

Authors: E R Block; J E Bennett; L G Livoti; W J Klein; R R MacGregor; L Henderson
Journal: Ann Intern Med Date: 1974-05 Impact factor: 25.391

6. 5-Fluorocytosine in the treatment of candidiasis with acute renal insufficiency: its kinetics during haemodialysis and peritoneal dialysis.

Authors: E Drouhet; P Babinet; J P Chapusot; D Kleinknecht
Journal: Biomedicine Date: 1973-09-20

7. Management of Candida peritonitis by prolonged peritoneal lavage containing 5-fluorocytosine.

Authors: S R Holdsworth; R C Atkins; D F Scott; R Jackson
Journal: Clin Nephrol Date: 1975-10 Impact factor: 0.975

8. Use of 5-fluorocytosine in patients with impaired renal function.

Authors: J K Dawborn; M D Page; D J Schiavone
Journal: Br Med J Date: 1973-11-17

9. Candida peritonitis complicating peritoneal dialysis: successful treatment with low dose amphotericin B therapy.

Authors: I N Mandell; M J Ahem; A S Kliger; V T Andriole
Journal: Clin Nephrol Date: 1976-11 Impact factor: 0.975

10. The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluorocytosine-2-14-C in man.

Authors: B A Koechlin; F Rubio; S Palmer; T Gabriel; R Duschinsky
Journal: Biochem Pharmacol Date: 1966-04 Impact factor: 5.858

6 in total

Review 1. Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review.

Authors: R Janknegt; C H Koks
Journal: Pharm Weekbl Sci Date: 1984-12-14

Review 2. Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?

Authors: Daniela Baracaldo-Santamaría; Juan David Cala-Garcia; Germán José Medina-Rincón; Luis Carlos Rojas-Rodriguez; Carlos-Alberto Calderon-Ospina
Journal: Antibiotics (Basel) Date: 2022-05-12

3. Therapeutic Drug Monitoring of Amphotericin-B in Plasma and Peritoneal Fluid of Pediatric Patients after Liver Transplantation: A Case Series.

Authors: Francesca Tortora; Luigi Dei Giudici; Raffaele Simeoli; Fabrizio Chiusolo; Sara Cairoli; Paola Bernaschi; Roberto Bianchi; Sergio Giuseppe Picardo; Carlo Dionisi Vici; Bianca Maria Goffredo
Journal: Antibiotics (Basel) Date: 2022-05-11